The phrase "also displayed a significant decrease in" is correct and usable in written English.
It can be used when discussing changes or trends in data, particularly in research or analytical contexts.
Example: "The study found that the experimental group also displayed a significant decrease in anxiety levels after the treatment."
Alternatives: "also showed a notable reduction in" or "also exhibited a marked decline in".
CNP::EGFP control mice also displayed a significant decrease in corpus callosum (CC) thickness and MBP immunoreactivity.
These cells also displayed a significant decrease in P-Ser-HP1γ staining by immunofluorescence, demonstrating that localization of P-Ser-HP1γ to the mitotic spindle pole was unambiguous.
In vitro-cultivated type B plants also displayed a significant decrease in the contents of carbohydrates, fatty acids and organic acids, and an increase in the levels of selected amino acids, polyamines and antioxidants [ 27].
Compared to Δ hapX, Δ hapXcccA OE also displayed a significant decrease in growth and sporulation on BPS- and low-iron agar plates, demonstrating that activation of vacuolar iron storage is particularly detrimental in a HapX-deficient background.
Cartilage samples derived from adult steer joints also displayed a significant decrease in sGAG biosynthesis after exposure to the pulsed EMF (control group, 391.1 ± 107.8 c.p.m./μg of hydroxyproline; 'pulsed EMF' group, 262.2 ± 50.9 c.p.m./μg of hydroxyproline; p < 0.008; Figure 5b), indicating a 33% decrease in isotope uptake and thus shows the susceptibility to EMF also of adult cartilage.
Moreover, consistent with previous observations (23, 34), male 'Non-Rescue' mice also displayed a significant decrease in their peak hippocampal theta frequency during periods of behavioral exploration relative to male wild-type mice (7.3 ± 0.1 versus 8.7 ± 0.2 Hz, respectively; P < 0.01, P < 0.01, one-way ANOVA, Fig. 5C).
In contrast, the WiR also displayed a significant decrease of the whole tumor (p ≤ 0.01) and the small hypervascular tumor areas (baseline: 37.5; SD 32.6/follow-up: 11.7; SD 8.3//baseline: 102.8; SD 76.8/follow-up: 25.5; SD 14.3) in the therapy group.
Adalimumab-treated Spalsotients also displayed a significant decrease of VEGF after 36 to 52 weeks.
Expression of the macrophage marker CD68 also displayed a significant decrease beyond passage three (Additional file 3).
Non-HDL cholesterol levels also displayed a significant decrease after statin therapy (3.8 ± 1.5 versus 2.5 ± 1.3 mmol/L, P = 0.0003).
Furthermore, we also found that SW1990/FBW7T205A cells displayed a significant decrease in cell migration ability (Supplementary information, Figure S6A and S6B).
